TP53 and breast carcinoma: Chandler et al. assessed the variations occurring in the expressions of Zn transporters and MTs in breast cancer cell lines and noted that MT was only overexpressed in basal-like MDA-MB-231 cells (p53 mutant and ER-) instead of T47D cells (p53 mutant and ER+).